Relationships Between Chemotherapy, Chemotherapy Dose Intensity and Outcomes of Follicular Lymphoma in the Immunochemotherapy Era: A Report from the University of Iowa/Mayo Clinic SPORE Molecular Epidemiology Resource

The optimal treatment of follicular lymphoma (FL) is not established. Rituximab is an important component of FL treatment making the impact of chemotherapy on FL less clear. We reviewed 649 FL at the University of Iowa/Mayo Clinic from 2002 to 2009 looking for the association of total dose delivery...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Leuk Lymphoma
Auteurs principaux: Wudhikarn, K., Smith, B. J., Button, A. M., Habermann, T. M., Thompson, C. A., Rosenstein, L. J., Syrbu, S. I., Weiner, G. J., Cerhan, J. R., Link, B. K.
Format: Artigo
Langue:Inglês
Publié: 2015
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4530103/
https://ncbi.nlm.nih.gov/pubmed/25530345
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2014.994206
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires